Mednet Logo

What is the general approach for HPV+ OPSCC who present with distant metastases?

How do you decide if/when to treat the primary disease and when would you treat definitively?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Texas MD Anderson Cancer Center
Answered on

It depends in part on the extent of the distant disease. In a true oligometastatic with one or two lesions, I would still take a curative approach with the appropriate management of the metastatic site. We would likely have a discussion on whether it is M1 to start with induction therapy, but I thin...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · UT Southwestern School of Medicine
Answered on

I agree with the superb answers thus far. Patients with synchronous metastases need control of their micrometastatic as well as gross disease, and thus starting with systemic therapy (IO/chemotherapy) has been our standard. This approach also provides an opportunity to assess treatment sensitivity, ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology
Answered on · Updated on

This is a great question with a lot of variances in practice, I feel.

So, for what my two pennies are worth:

Regardless of HPV status, I often favor an upfront definitive local H&N regimen in many patients that p/w limited DMs; primarily since the morbidity of future airway-related issues/mortality ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Veterans Administration Hospital, Jackson,MS
Answered on

The patient has metastatic disease. Thus, any radiation therapy is an adjunct to chemotherapy. Unless the primary is exceptionally large and symptomatic, I would recommend upfront chemotherapy. Further treatment will depend on the response to treatment chemotherapy. I will treat the head and neck ev...

Join for free or sign in to see the full answer